Zacks Investment Research upgraded shares of Torchmark (NYSE:TMK) from a hold rating to a buy rating in a research report report published on Thursday, January 11th. Zacks Investment Research currently has $103.00 target price on the insurance provider’s stock.
According to Zacks, “Shares of Torchmark have outperformed the industry in a year. Torchmark’s niche market focus, steady capital deployment and strong operating fundamentals should drive long-term growth. The insurer estimates life and health sales growth in distribution channels. Also, a strong capital position and capital management are key positives. Torchmark now expects net operating income between $4.77 and $4.83 per share in 2017 on positive outlook for life underwriting income at American Income and health insurance businesses. For 2018, it guides the bottom line between $5 and $5.25 per share. Life underwriting income is to grow in 4%-5% range while health underwriting income in 3%-5% range. However, higher administrative expenses (6.4% of premium in 2017), pension costs and investments in IT systems will likely be a drag on Torchmark’s earnings in the near term.”
Several other analysts have also recently weighed in on the stock. ValuEngine upgraded shares of Torchmark from a hold rating to a buy rating in a report on Sunday, December 31st. Keefe, Bruyette & Woods reissued a hold rating and set a $78.00 price objective on shares of Torchmark in a research report on Sunday, October 8th. SunTrust Banks raised their price objective on Torchmark from $75.00 to $85.00 and gave the company a hold rating in a research report on Thursday, October 26th. Finally, Goldman Sachs Group started coverage on Torchmark in a research report on Wednesday, October 18th. They issued a neutral rating and a $83.00 price target for the company. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $84.20.
Torchmark (NYSE TMK) opened at $83.96 on Thursday. The stock has a market cap of $10,183.56, a P/E ratio of 18.65, a PEG ratio of 2.11 and a beta of 0.93. Torchmark has a fifty-two week low of $73.53 and a fifty-two week high of $93.60. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.22.
The company also recently declared a quarterly dividend, which was paid on Thursday, February 1st. Shareholders of record on Friday, January 5th were paid a dividend of $0.15 per share. The ex-dividend date was Thursday, January 4th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.71%. Torchmark’s dividend payout ratio is currently 12.77%.
In related news, insider Roger C. Smith sold 30,000 shares of the business’s stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $90.64, for a total transaction of $2,719,200.00. Following the completion of the transaction, the insider now directly owns 65,685 shares in the company, valued at approximately $5,953,688.40. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Vern D. Herbel sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $83.89, for a total value of $2,097,250.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 96,250 shares of company stock valued at $8,563,383. Corporate insiders own 3.79% of the company’s stock.
A number of hedge funds have recently bought and sold shares of TMK. Tiedemann Wealth Management LLC boosted its stake in Torchmark by 8.0% in the 3rd quarter. Tiedemann Wealth Management LLC now owns 16,147 shares of the insurance provider’s stock worth $127,000 after purchasing an additional 1,201 shares during the period. Fuller & Thaler Asset Management Inc. boosted its stake in Torchmark by 63.6% in the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 1,800 shares of the insurance provider’s stock worth $144,000 after purchasing an additional 700 shares during the period. Invictus RG bought a new position in Torchmark in the 3rd quarter worth approximately $165,000. Cerebellum GP LLC bought a new position in Torchmark in the 4th quarter worth approximately $173,000. Finally, Assetmark Inc. boosted its stake in Torchmark by 7,975.0% in the 3rd quarter. Assetmark Inc. now owns 2,261 shares of the insurance provider’s stock worth $181,000 after purchasing an additional 2,233 shares during the period. Institutional investors and hedge funds own 73.15% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Zacks Investment Research Upgrades Torchmark (NYSE:TMK) to Buy” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/02/06/torchmark-tmk-stock-rating-upgraded-by-zacks-investment-research.html.
Torchmark Company Profile
Torchmark Corporation (Torchmark) is an insurance holding company. The Company, through its subsidiaries, provides a range of life and health insurance products and annuities to a base of customers. The Company’s segments include life insurance, health insurance, annuities and investment. The life insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurance.
Get a free copy of the Zacks research report on Torchmark (TMK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Torchmark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Torchmark and related companies with MarketBeat.com's FREE daily email newsletter.